224
Participants
Start Date
April 25, 1997
Primary Completion Date
April 12, 2001
Study Completion Date
December 15, 2008
filgrastim
cisplatin
cyclophosphamide
mitoxantrone hydrochloride
tamoxifen citrate
Tom Baker Cancer Center - Calgary, Calgary
BC Cancer Agency, Vancouver
CancerCare Manitoba, Winnipeg
Moncton Hospital, Moncton
Saint John Regional Hospital, Saint John
Newfoundland Cancer Treatment and Research Foundation, St. John's
Nova Scotia Cancer Centre, Halifax
William Osler Health Centre, Brampton
Northeastern Ontario Regional Cancer Centre, Sudbury, Greater Sudbury
Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton
Cancer Care Ontario-London Regional Cancer Centre, London
Ottawa Regional Cancer Centre - General Campus, Ottawa
Hotel Dieu Hospital - St. Catharines, St. Catharines
Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay
Toronto Sunnybrook Regional Cancer Centre, Toronto
Toronto General Hospital, Toronto
Princess Margaret Hospital, Toronto
Humber River Regional Hospital, Weston
Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor
Queen Elizabeth Hospital, PEI, Charlottetown
L'Hotel Dieu de Levis, Lévis
Centre Hospitalier de l'Universite de Montreal, Montreal
McGill University Department of Oncology, Montreal
Hotel Dieu de Montreal, Montreal
Centre Hospitalier Universitaire de Quebec, Pavillion de Quebec, Québec
Lead Sponsor
NCIC Clinical Trials Group
NETWORK